Congresswoman Schrier Introduces Bipartisan Legislation to Improve Public Health Preparedness
WASHINGTON, D.C. –Congresswoman Kim Schrier, M.D. (WA-08) introduced the bipartisan Diagnostics Testing Preparedness Plan Act, which would facilitate the innovation and development of diagnostics between the private and public sectors during Public Health Emergencies. Congresswoman Schrier was joined in introducing this legislation by Representatives Miller-Meeks (IA-01), Carson (IN-07), and Crenshaw (TX-02).
“Diagnostics are an essential part of public health preparedness and, as was exemplified in the COVID-19 Pandemic when we struggled to provide the testing required to slow the spread of disease while South Korea was doing thousands of drive-thru tests daily, diagnostic testing is especially crucial during a public health emergency,” said Congresswoman Schrier, M.D. “This commonsense, bipartisan bill will improve our clinical and diagnostic laboratory testing capacity, enhance public-private partnerships, and strengthen our overall public health preparedness against illnesses ranging from the seasonal flu to new, emerging threats.”
The Diagnostics Testing Preparedness Plan Act would require the Department of Health and Human Services (HHS) to develop a strategic plan that supports the rapid deployment of diagnostic tests during public health emergencies. Specifically, HHS would develop and periodically update a plan for rapid development, procurement, and distribution of diagnostic tests during public health emergencies, including laboratory and at-home tests. The plan must promote collaboration among government agencies and private sector stakeholders.
“From development to distribution, it is crucial to have a comprehensive plan for diagnostic and clinical lab testing capacities during a public health emergency,” said Dr. Miller-Meeks. “During the COVID-19 pandemic, we saw how critical diagnostic tests were for the public health response. As a physician, I am proud to sponsor this bipartisan bill to ensure the U.S. has a robust response to future public health emergencies.”
“Diagnostics play a role in every aspect of public health,” said Congressman Carson. “Whether it’s a bad flu season or the outbreak of a new infectious disease like the bird flu, our bill will ensure my district and cities across the country are better coordinated and better prepared to tackle the world’s most serious health problems. I’m honored to work with Roche Diagnostics in my home district and with my colleagues across the aisle on this important bill.”